Aimmune Therapeutics
Brisbane, CA
Aimmune Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing treatments to protect children with food allergies from accidental exposure. Aimmune Therapeutics serves customers in the United States.
aimmune.comCompany Details
Founded
- 2011
Employees
- Between 215 - 1,000 employees
Raised
- $540,000,000
Headquarters Location
- Brisbane, CA
Public
- Yes
Acquired
- Yes
Founders
- Bryan Walser
Company Collections
These are collections Aimmune Therapeutics is a part of. Click on the collection name to view similar companies.
Aimmune Therapeutics' Industries
Aimmune Therapeutics' Tech Stack
Aimmune Therapeutics Headquarters Location
8000 Marina Blvd ste 300, Brisbane, CA 94005-1884
Total Amount Raised: $540,000,000
Aimmune Therapeutics Funding Rounds
Post Ipo Equity
$200,000,000
Post Ipo Equity Investors
Nestlé Health SciencePost Ipo Equity
$98,000,002
Post Ipo Equity Investors
Nestlé Health SciencePost Ipo Equity
$145,000,000
Post Ipo Equity Investors
Nestlé Health ScienceSeries B
$80,000,000
Series B Investors
Foresite CapitalLongitude CapitalFidelityAisling CapitalAdage Capital ManagementRA Capital ManagementIPO
Unknown
Series A
$17,000,000
Series A Investors
Longitude Capital
Funding info provided by Diffbot.
Aimmune Therapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Aimmune Therapeutics.